Christopher C Oakes Selected Research

B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

1/2024	Prediction of outcomes for high-count monoclonal B lymphocytosis using an epigenetic and immunogenetic signature.
1/2019	Developmental subtypes assessed by DNA methylation-iPLEX forecast the natural history of chronic lymphocytic leukemia.
1/2019	Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: results from 3 UK clinical trials.
11/2016	Surface IgM expression and function are associated with clinical behavior, genetic abnormalities, and DNA methylation in CLL.
1/2016	High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells.
7/2014	Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemia.
1/2013	Germline allele-specific expression of DAPK1 in chronic lymphocytic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christopher C Oakes Research Topics

Disease

13	Neoplasms (Cancer) 02/2024 - 01/2015
7	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2024 - 01/2013
2	Lymphocytosis 02/2024 - 01/2024
2	Trisomy (Trisomies) 10/2023 - 01/2018
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2017
2	Radiation Fibrosis Syndrome (Radiation Fibrosis) 10/2017 - 03/2016
2	Fibrosis (Cirrhosis) 10/2017 - 03/2016
2	Leukemia 01/2016 - 09/2015
1	Hematologic Neoplasms (Hematological Malignancy) 01/2023
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2022
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2020
1	Lymphoma (Lymphomas) 01/2020
1	Primary Myelofibrosis (Myelosclerosis) 01/2020
1	Laryngeal Neoplasms (Laryngeal Cancer) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 05/2016
1	Prostatic Neoplasms (Prostate Cancer) 01/2015
1	Neoplasm Metastasis (Metastasis) 01/2015
1	Neuroblastoma 12/2014
1	Breast Neoplasms (Breast Cancer) 01/2013

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2019 - 12/2014
3	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 12/2014
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 03/2015
3	Messenger RNA (mRNA)IBA 01/2017 - 01/2013
2	AntigensIBA 01/2023 - 11/2016
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 03/2016
2	Decitabine FDA Link 01/2020 - 12/2014
2	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2018 - 07/2014
2	Diacylglycerol KinaseIBA 10/2017 - 03/2016
1	ChemokinesIBA 10/2023
1	Histone Deacetylase InhibitorsIBA 01/2023
1	Non-Receptor Type 11 Protein Tyrosine PhosphataseIBA 01/2022
1	A-Form DNA (A-DNA)IBA 11/2020
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 01/2020
1	Janus Kinase InhibitorsIBA 01/2020
1	serum P-component (CIt)IBA 01/2019
1	Exonucleases (3' 5' Exonuclease)IBA 01/2019
1	IGF-I-IGFBP-3 complex FDA Link 01/2019
1	thiamine triphosphorate (TTP)IBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2018
1	ChromatinIBA 10/2017
1	B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA 11/2016
1	venetoclaxIBA 01/2016
1	MicroRNAs (MicroRNA)IBA 09/2015
1	LuciferasesIBA 09/2015
1	A-factor (Streptomyces)IBA 01/2015
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2014
1	NucleotidesIBA 07/2014
1	DNA Polymerase gammaIBA 01/2013
1	Death-Associated Protein KinasesIBA 01/2013
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2013

Therapy/Procedure

7	Therapeutics 02/2024 - 10/2017
2	Radiotherapy 10/2017 - 03/2016
1	Drug Therapy (Chemotherapy) 01/2022
1	Immunotherapy 01/2020
1	Aftercare (After-Treatment) 01/2019
1	Precision Medicine 01/2018